Outcome of Board Meeting held on November 13, 2026
As filed · Natural Capsules Limited has informed the Exchange regarding Outcome of Board Meeting held on November 13, 2026.
What happened
Factamended, in-principle approvals received from BSE Limited and National Stock Exchange of India Limited on November. to subscribe to 1 (one) fully paid-up Equity Share of face value Z10/- each upon receipt of 25% upfront. The Board Meeting commenced at 2:30 PM and concluded at 6:30 PM.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Guidance
DelayedCommercial sales initiated in Q4FY26; facility scaling up with quality systems in place — focused on expanding into regulated markets and geographies with stronger profitability profile
Revenue from this line is expected to commence in the second half of FY27, subject to customer qualification and approval in the US market.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Commercial sales finally commenced in Q4FY26, and we are now focused on growing these volumes gradually over t (management committed by FY27)
- The incremental sales from the new HPMC line should further support profitability through the year. (management committed by FY27)
Evidence
- Natural Capsules Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.(opens the original filing in a new tab)
- Earlier statement · Q4 FY26
- Latest statement · Q4 FY26
- Earlier statement · Q4 FY26
How CapitSignal classified this
- Reasoning:
- BOARD_MEETING base 22; +6 corroborating keywords; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%